Sustained and rebound effect of repeated low‐level red‐light therapy on myopia control: A 2‐year post‐trial follow‐up study
Clinical and Experimental Ophthalmology2022Vol. 50(9), pp. 1013–1024
Citations Over TimeTop 1% of 2022 papers
Ruilin Xiong, Zhuoting Zhu, Yu Jiang, Xiangbin Kong, Jian Zhang, Wei Wang, Katerina Kiburg, Yixiong Yuan, Yanping Chen, Shiran Zhang, Meng Xuan, Junwen Zeng, Ian G. Morgan, Mingguang He
Abstract
Continued RLRL therapy sustained promising efficacy and safety in slowing myopia progression over 2 years. A modest rebound effect was noted after treatment cessation.
Related Papers
- Susquehanna Chorale Spring Concert "Roots and Wings"(2017)
- → DETERMINING QUALITY REQUIREMENTS AT THE UNIVERSITIES TO IMPROVE THE QUALITY OF EDUCATION(2018)
- → Genentech taps Affimed’s antibodies(2018)
- Enxerto livre de arteria epigastrica inferior: avaliacao hemodinamica e angiografica pre e pos-operatoria(1988)
- → KOMPLIKASI REGIONAL ANESTESI PADA PEDIATRIK(2023)